SUN PHARMA ADVANCED RESEARCH COMPANY LTD. Q3 FY25 Results
SPARCQ3 FY25 ResultsAnnounced 10 Feb 2025, 07:56 pm| Metric | Value (₹ Cr) | vs Q2 FY25 |
|---|---|---|
| Revenue | 14.91 | 15.9% |
| Total Income | 15.10 | 17.1% |
| Expenditure | 94.54 | 21.3% |
| PBT | -79.44 | 25.9% |
| Net Profit | -79.51 | 25.9% |
| OPM | — | |
| NPM | — | |
| EPS | -2.45 | 26.0% |
Informational and educational content only. Not investment advice.